Abstract
Akinesia is one of the most frequently used terms in the symptomatology of parkinsonism. The term includes various symptoms, and sometimes it is not easy to define akinesia clearly and strictly, especially when its generating mechanism is discussed (Barbeau 1971; Hornykiewicz 1972). In this paper I would like to propose at least three different subgroups of akinesia in the clinical sense, considering their physiological and pharmacological mechanisms (Narabayashi 1980). Parkinsonian facies, poor blinking, low voice and dysarthria, stuttering festination of speech, lack of arm-swing in walking, poverty and slowness of movement, awkwardness in coordinated movements and many other difficulties in motor performance of daily activities are included in the term akinesia. Not all of these symptoms can be considered to be due to one single mechanism, but may be due to several different mechanisms in their generation. Group A consists of symptoms which belong to the category of slowness and awkwardness of movement, especially of coordinated movement, and group B is the group of symptoms belonging to the category of poverty or lack of movement. Group C is the so-called freezing phenomenon at the start of movement or festination of repetitive movements.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barbeau A (1971) Long-term side-effects of Levodopa. Lancet 1: 395
Hornykiewicz O (1972) Biochemical and pharmacological aspects of akinesia. In: Siegfried J (ed) Parkinson’s disease, vol 1. Huber, Bern, pp 127–149
Martin J (1967) The basal ganglia and posture. Pitman, London, p 17
Nagatsu T, Kato T, Nagatsu I, Kondo Y, Inagaki S, Iizuka R, Narabayashi H (1979) Catecholamine-related enzymes in the brain of patients with parkinsonism and Wilson’s disease. Adv Neurol 24: 283–292
Nagatsu T, Wakui Y, Kato T, Fujita K, Kondo T, Yokochi F, Narabayashi H (1982) Dopamine beta-hydroxylase activity in cerebrospinal fluid of parkinsonian patients. Biomed Res 3: 95–98
Nakamura R, Nagasaki H, Narabayashi H (1976) Arrhythmokinesia in parkinsonism. In: Birkmayer W, Hornykiewicz O (eds) Advances in parkinsonism. Hoffmann-La Roche, Basel, pp 258–268
Narabayashi H (1980) Clinical analysis of akinesia. J Neural Transm (Suppl) 16: 129–136
Narabayashi H, Nakamura R (1981) The freezing phenomenon — Problems in long-term L-dopa treatment for parkinsonism. In: Rose FC, Capildeo R (eds) Research progress in parkinson’s disease. Pitman, Tunbridge Wells, pp 248–253
Narabayashi H, Imai H, Yokochi M, Hirayama K, Nakamura R (1976) Cases of pure akinesia without rigidity and tremor and with no effect by L-dopa therapy. In: Birkmayer W, Hornykiewicz O (eds) Advances in parkinsonism. Hoffmann-La Roche, Basel, pp 335–342
Narabayashi H, Kondo T, Hayashi A, Suzuki T, Nagatsu T (1981) L-threo-3,4-dihydroxyphenylserine treatment for akinesia and freezing of parkinsonism. Proc Jpn Acad (B) 57: 351–354
Narabayashi H, Kondo T, Hayashi A, Suzuki T, Nagatsu T (1983) L-threo-3,4-dihydroxyphenylserine for treatment of freezing and akinesia of parkinsonism. In: Yahr MD (ed) Current concepts of Parkinson disease and related disorders. Excerpta Medica, Princeton
Ohye C, Tsukahara H, Narabayashi H (1965) Rigidity and disturbance of reciprocal innervation.Confin Neurol 26: 24–40
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Narabayashi, H. (1985). Analysis of Akinesia. In: Gerstenbrand, F., Poewe, W., Stern, G. (eds) Clinical Experiences with Budipine in Parkinson Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-95455-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-95455-9_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-13764-1
Online ISBN: 978-3-642-95455-9
eBook Packages: Springer Book Archive